Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk, the Danish pharmaceutical company also responsible for semaglutide (Ozempic, Wegovy)
How GLP-1 Drugs Target Both at Once GLP-1 receptor agonists were designed for metabolic purposes: regulating blood sugar, slowing gastric emptying, and reducing appetite
[2] It is a highly conserved system found primarily in animals/some eukaryotes, although bacteria and plants still use carnitine for other things such as being an osmoprotectant, or being and electron acceptor in the electron transport chain
Theres definitely a glass ceiling
However, in a subanalysis of participants with low vitamin B 12 status at baseline (n= 101), the B-vitamin supplementation slowed the decline in bone mineral density (total hip and femoral neck but not lumbar spine) (116)
doi: 10.1111/j.1365-2222.2008.02958.x 33 KvideraSKHorstEAAbuajamiehMMayorgaEJFernandezMVBaumgardLH